AstraZeneca Expands Prescription Savings Program

WILMINGTON, Del., July 23  /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today it is expanding its prescription savings program by immediately extending assistance to qualifying patients who have recently lost their jobs, had their incomes reduced, or experienced a change in marital status or family size.

Previously, patients who experienced a change in income or family size had difficulty applying to the program if their W2 statements showed a non-qualifying income.  Now, qualifying people who provide documentation of their current income and family size can enroll more easily and receive their AstraZeneca medicines more quickly.

"AstraZeneca is committed to helping patients get the medicines they need," said Rich Fante, US President, AstraZeneca Pharmaceuticals LP. "Our responsibility goes beyond developing medicines to also making them available to those who cannot afford them."

For more than 30 years, AstraZeneca has offered patient assistance programs side-by-side with its medicines. In 2008, AstraZeneca helped more than 440,000 people fill 2.7 million prescriptions resulting in $612 million of savings to patients.

AstraZeneca provides free or low-cost medicines to patients through its AZ&Me(TM) Prescription Savings programs in three ways:

  --  AZ&Me(TM) Prescription Savings program for people without insurance:
      AstraZeneca provides AstraZeneca medicines at no cost to qualifying
      individuals without prescription drug coverage who make up to $30,000
      per year and families of four who make up to $60,000 per year.
  --  AZ&Me(TM) Prescription Savings program for people with Medicare Part
      D: AstraZeneca provides low-cost AstraZeneca medicines for qualifying
      Medicare Part D patients who make up to $30,000 per year or couples
      who make up to $40,000 per year.

  --  AZ&Me(TM) Prescription Savings program for healthcare facilities:
      AstraZeneca provides AstraZeneca medicines at no cost to qualifying
      non-profit healthcare facilities, such as disproportionate share
      hospitals, community health centers and community free clinics. This
      program connects patients to the AstraZeneca medicines they need at
      the same time and place they receive their treatment.



Patients can learn more about the AZ&Me(TM) Prescription Savings program at http://www.azandme.com/ or by calling 1-800-AZandMe.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines.  In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: http://www.astrazeneca-us.com/. 

DATASOURCE: AstraZeneca



CONTACT:  Tony Jewell of AstraZeneca, [phone]



Web Site:  http://www.astrazeneca-us.com/ 

Copyright